Prime Medicine, Inc. (PRME) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Prime Medicine, Inc. (PRME) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PRME Income Statement

Prime Medicine, Inc. (PRME) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	1.15M	856K	838K	1.23M	1.11M	1.45M	2.18M	209K	0	591K	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	3.5%	-41.13%	-61.61%	486.12%	-	146.02%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	1.86M	0	43.99M	1.86M	0	0	0	0	1.31M	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	216.82%	-	3591.02%	167.17%	-	-	-	-	222.5%	-	-	-	-	-	-	-	-	-	-
Gross Profit	1.15M	-1M	838K	-42.77M	-749K	1.45M	2.18M	209K	0	-724K	0	0	0	0	0	0	0	0	0	0
Gross Margin %	100%	-116.82%	100%	-3491.02%	-67.17%	100%	100%	100%	-	-122.5%	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	254.07%	-168.78%	-61.61%	-20561.72%	-	300.83%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	44.44M	49.65M	49.45M	11.21M	52.63M	53.85M	46.41M	54.44M	55.67M	47.62M	68.04M	51.46M	45.26M	40.03M	38.69M	31.66M	26.3M	19.9M	60.08M	10.43M
OpEx % of Revenue	3850.87%	5800.7%	5900.48%	914.94%	4720%	3703.3%	2125.74%	26048.33%	-	8057.02%	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	11.04M	17.41M	14.74M	11.21M	13.12M	13.28M	12.3M	14.1M	12.6M	11.16M	13.08M	10.49M	10.66M	9.15M	9.63M	6.61M	7.37M	6.22M	7.19M	3.03M
SG&A % of Revenue	956.85%	2033.29%	1758.59%	914.94%	1176.41%	913.62%	563.49%	6746.89%	-	1887.99%	-	-	-	-	-	-	-	-	-	-
Research & Development	33.4M	34.1M	34.71M	43.99M	41.38M	40.56M	34.1M	40.34M	43.07M	37.77M	41.46M	40.97M	34.6M	30.88M	29.06M	25.05M	18.94M	13.68M	52.89M	7.4M
R&D % of Revenue	2894.02%	3984.23%	4141.89%	3591.02%	3710.76%	2789.68%	1562.25%	19301.44%	-	6391.54%	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	-1000K	0	-1000K	-1000K	0	0	0	0	-1000K	1000K	-1K	0	0	0	0	0	0	0	0
Operating Income	-43.28M	-50.65M	-48.61M	-53.97M	-53.38M	-52.39M	-44.22M	-54.23M	-55.67M	-48.34M	-68.04M	-51.46M	-45.26M	-40.03M	-38.69M	-31.66M	-26.3M	-19.9M	-60.08M	-10.43M
Operating Margin %	-3750.87%	-5917.52%	-5800.48%	-4405.96%	-4787.17%	-3603.3%	-2025.74%	-25948.33%	-	-8179.53%	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	18.91%	3.32%	-9.92%	0.48%	4.12%	-8.38%	35.01%	-5.39%	-23.01%	-20.75%	-75.89%	-62.56%	-72.05%	-101.19%	35.6%	-203.59%	-	-	-	-
EBITDA	-41.5M	-48.8M	-46.73M	-52.09M	-51.51M	-50.69M	-42.51M	-52.67M	-54.13M	-47.03M	-66.8M	-50.22M	-44.14M	-38.98M	-37.82M	-31.02M	-25.88M	-19.61M	-59.85M	-10.26M
EBITDA Margin %	-3596.19%	-5700.7%	-5576.61%	-4252.41%	-4620%	-3486.38%	-1947.09%	-25202.87%	-	-7957.02%	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	19.44%	3.74%	-9.94%	1.1%	4.84%	-7.8%	36.37%	-4.88%	-22.64%	-20.64%	-76.63%	-61.88%	-70.59%	-98.83%	36.81%	-202.38%	-	-	-	-
D&A (Non-Cash Add-back)	1.78M	1.86M	1.88M	1.88M	1.86M	1.7M	1.72M	1.56M	1.54M	1.31M	1.25M	1.24M	1.12M	1.05M	870K	631K	430K	293K	229K	167K
EBIT	-42.11M	-49.12M	-46.08M	-50.58M	-52.59M	-51.89M	-42.28M	-52.52M	-55.46M	-45.63M	-54.54M	-51.46M	-45.26M	-40.03M	-38.69M	-31.66M	-26.3M	-19.9M	-60.08M	-10.43M
Net Interest Income	788K	1.48M	1.08M	1.14M	1.27M	1.18M	1.54M	697K	611K	676K	0	410K	635K	0	0	0	0	0	0	0
Interest Income	788K	1.48M	1.08M	1.14M	1.27M	1.18M	1.54M	697K	611K	676K	0	410K	635K	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	1.18M	1.53M	2.53M	3.39M	786K	502K	1.95M	1.71M	211K	2.71M	2.4M	643K	2.9M	434K	-783K	2.52M	-3.48M	-4.47M	-1.45M	-8.36M
Pretax Income	-42.11M	-49.12M	-46.08M	-50.58M	-52.59M	-51.89M	-42.28M	-52.52M	-55.46M	-45.63M	-65.64M	-50.82M	-42.35M	-39.6M	-39.47M	-29.14M	-29.79M	-24.37M	-61.53M	-18.78M
Pretax Margin %	-3648.96%	-5738.55%	-5498.69%	-4129.14%	-4716.68%	-3568.78%	-1936.6%	-25128.23%	-	-7720.3%	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	-134K	134K	0	-108K	31K	-202K	-186K	212K	-442K	-532K	1.38M	-2.37M
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0.24%	-0.29%	0%	0.21%	-0.07%	0.51%	0.47%	-0.73%	1.48%	2.18%	-2.24%	12.62%
Net Income	-42.11M	-49.12M	-46.08M	-50.58M	-52.59M	-51.89M	-42.28M	-52.52M	-55.33M	-45.76M	-65.64M	-50.71M	-42.38M	-39.4M	-39.28M	-35.71M	-29.35M	-23.84M	-62.91M	-16.41M
Net Margin %	-3648.96%	-5738.55%	-5498.69%	-4129.14%	-4716.68%	-3568.78%	-1936.6%	-25128.23%	-	-7742.98%	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	19.93%	5.33%	-9%	3.69%	4.95%	-13.39%	35.6%	-3.57%	-30.53%	-16.15%	-67.1%	-41.99%	-44.42%	-65.26%	37.56%	-117.6%	-	-	-	-
Net Income (Continuing)	-42.11M	-49.12M	-46.08M	-50.58M	-52.59M	-51.89M	-42.28M	-52.52M	-55.33M	-45.76M	-65.64M	-50.71M	-42.38M	-39.4M	-39.28M	-29.35M	-29.35M	-23.84M	-62.91M	-16.41M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.24	-0.28	-0.26	-0.32	-0.41	-0.40	-0.36	-0.44	-0.46	-0.44	-0.67	-0.55	-0.47	-0.44	-0.42	-0.37	-0.37	-0.31	-0.72	-0.24
EPS Growth %	41.05%	29.38%	27.07%	27.02%	12.3%	9.47%	47.11%	20.58%	0.92%	0.97%	-61.42%	-50.27%	-25.84%	-40.86%	42.29%	-54.43%	-	-	-	-
EPS (Basic)	-0.24	-0.28	-0.26	-0.32	-0.41	-0.40	-0.36	-0.44	-0.46	-0.44	-0.67	-0.55	-0.47	-0.44	-0.42	-0.37	-0.37	-0.31	-0.72	-0.24
Diluted Shares Outstanding	177.22M	177.1M	148.76M	160.5M	129.19M	130.88M	118.6M	119.76M	119.19M	104.47M	97.38M	91.85M	90.47M	89.06M	97.21M	97.21M	95.73M	95.73M	95.73M	95.73M
Basic Shares Outstanding	177.22M	177.1M	148.76M	160.5M	129.19M	130.88M	118.6M	119.76M	119.19M	104.47M	97.38M	91.85M	90.47M	89.06M	97.21M	97.21M	95.73M	95.73M	95.73M	95.73M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-